The transcription factor HIF-1α in NKp46+ ILCs limits chronic intestinal inflammation and fibrosis.
Eric NeliusZheng FanMichal SobeckiEwelina KrzywinskaShunmugam NagarajanIrina FerapontovaDagmar GotthardtNorihiko TakedaVeronika SexlChristian StockmannPublished in: Life science alliance (2024)
Innate lymphoid cells (ILCs) are critical for intestinal adaptation to microenvironmental challenges, and the gut mucosa is characterized by low oxygen. Adaptation to low oxygen is mediated by hypoxia-inducible transcription factors (HIFs), and the HIF-1α subunit shapes an ILC phenotype upon acute colitis that contributes to intestinal damage. However, the impact of HIF signaling in NKp46 + ILCs in the context of repetitive mucosal damage and chronic inflammation, as it typically occurs during inflammatory bowel disease, is unknown. In chronic colitis, mice lacking the HIF-1α isoform in NKp46+ ILCs show a decrease in NKp46 + ILC1s but a concomitant rise in neutrophils and Ly6C high macrophages. Single-nucleus RNA sequencing suggests enhanced interaction of mesenchymal cells with other cell compartments in the colon of HIF-1α KO mice and a loss of mucus-producing enterocytes and intestinal stem cells. This was, furthermore, associated with increased bone morphogenetic pathway-integrin signaling, expansion of fibroblast subsets, and intestinal fibrosis. In summary, this suggests that HIF-1α-mediated ILC1 activation, although detrimental upon acute colitis, protects against excessive inflammation and fibrosis during chronic intestinal damage.
Keyphrases
- oxidative stress
- transcription factor
- stem cells
- endothelial cells
- induced apoptosis
- nk cells
- drug induced
- liver failure
- ulcerative colitis
- single cell
- cell cycle arrest
- respiratory failure
- type diabetes
- cell therapy
- metabolic syndrome
- cell death
- adipose tissue
- insulin resistance
- mesenchymal stem cells
- dna binding
- body mass index
- body composition
- acute respiratory distress syndrome
- cell migration
- aortic dissection
- extracorporeal membrane oxygenation
- postmenopausal women